Measurement of heparin, direct oral anti‐coagulants and other non‐coumarin anti‐coagulants and their effects on haemostasis assays: A British Society for Haematology Guideline-Reference-Cited by-同舟云学术

Measurement of heparin, direct oral anti‐coagulants and other non‐coumarin anti‐coagulants and their effects on haemostasis assays: A British Society for Haematology Guideline

Published:2024-09-02 Issue: Volume: Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Baker Peter¹^ORCID,Platton Sean²^ORCID,Arachchillage Deepa J.³⁴^ORCID,Kitchen Steve⁵,Patel Jignesh⁶,Riat Renu⁷,Gomez Keith⁸,

Affiliation:

1. Oxford Haemophilia and Thrombosis Centre Oxford University Hospitals NHS Foundation Trust Oxford UK

2. Royal London Hospital Haemophilia Centre Barts Health NHS Trust London UK

3. Centre for Haematology, Department of Immunology and Inflammation Imperial College London London UK

4. Department of Haematology Imperial College Healthcare NHS Trust London UK

5. Department of Coagulation Royal Hallamshire Hospital NHS Foundation Trust Sheffield UK

6. Department of Haematological Medicine Kings College Hospital NHS Foundation Trust London UK

7. Department of Haematology Buckinghamshire NHS Trust Amersham UK

8. Haemophilia and Thrombosis Unit Royal Free London NHS Foundation Trust London UK

Funder

British Society for Haematology

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.19729

Reference146 articles.

1. Measurement of non-Coumarin anticoagulants and their effects on tests of Haemostasis: Guidance from the British Committee for Standards in Haematology

2. An update on novel therapies for treating patients with arterial thrombosis

3. Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation

4. Simple method for removing DOACs from plasma samples

5. Resolving DOAC interference on aPTT , PT, and lupus anticoagulant testing by the use of activated carbon